Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32)
about
BCL10 expression in normal and neoplastic lymphoid tissue. Nuclear localization in MALT lymphomaCARD9 is a novel caspase recruitment domain-containing protein that interacts with BCL10/CLAP and activates NF-kappa BInterchangeable binding of Bcl10 to TRAF2 and cIAPs regulates apoptosis signalingMalt1 ubiquitination triggers NF-kappaB signaling upon T-cell activationcIAP2 is a ubiquitin protein ligase for BCL10 and is dysregulated in mucosa-associated lymphoid tissue lymphomasBcl10 can promote survival of antigen-stimulated B lymphocytesInherited BCL10 deficiency impairs hematopoietic and nonhematopoietic immunityAccumulation of BCL10 at the perinuclear region is required for the BCL10-mediated nuclear factor-kappa B activationDegradation of Bcl10 induced by T-cell activation negatively regulates NF-kappa B signalingCARD11 mediates factor-specific activation of NF-kappaB by the T cell receptor complex.CD3/CD28 costimulation-induced NF-kappaB activation is mediated by recruitment of protein kinase C-theta, Bcl10, and IkappaB kinase beta to the immunological synapse through CARMA1Combating the epigenome: epigenetic drugs against non-Hodgkin's lymphomaEquine herpesvirus protein E10 induces membrane recruitment and phosphorylation of its cellular homologue, bcl-10Regulatory mechanisms of TRAF2-mediated signal transduction by Bcl10, a MALT lymphoma-associated proteinBimp1, a MAGUK family member linking protein kinase C activation to Bcl10-mediated NF-kappaB inductionBcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathwayFunctional characterization of zebrafish (Danio rerio) Bcl10Physical and functional interaction of CARMA1 and CARMA3 with Ikappa kinase gamma-NFkappaB essential modulatorA Novel TRAF6 binding site in MALT1 defines distinct mechanisms of NF-kappaB activation by API2middle dotMALT1 fusionsCD28 stimulation triggers NF-kappaB activation through the CARMA1-PKCtheta-Grb2/Gads axisT(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphomaCaspase recruitment domain (CARD)-dependent cytoplasmic filaments mediate bcl10-induced NF-kappaB activationBCL10 mediates lipopolysaccharide/toll-like receptor-4 signaling through interaction with Pellino2The protein kinase C-responsive inhibitory domain of CARD11 functions in NF-kappaB activation to regulate the association of multiple signaling cofactors that differentially depend on Bcl10 and MALT1 for association.Lack of BCL10 mutations in Hodgkin's disease-derived cell lines.A loss-of-function RNA interference screen for molecular targets in cancer.Establishment of a pipeline to analyse non-synonymous SNPs in Bos taurusAuto-ubiquitination-induced degradation of MALT1-API2 prevents BCL10 destabilization in t(11;18)(q21;q21)-positive MALT lymphoma.B-cell CLL/lymphoma 10 (BCL10) is required for NF-kappaB production by both canonical and noncanonical pathways and for NF-kappaB-inducing kinase (NIK) phosphorylation.Diffuse large B-cell lymphoma: can genomics improve treatment options for a curable cancer?Helicobacter pylori and Gastric Mucosa-associated Lymphoid Tissue (MALT) Lymphoma: Updated Review of Clinical Outcomes and the Molecular PathogenesisOncogenic activation of NF-kappaB.CARMA1-mediated NF-kappaB and JNK activation in lymphocytes.Pathogenetic importance and therapeutic implications of NF-κB in lymphoid malignancies.BCMSUN, a candidate gene for B-cell chronic lymphocytic leukemia and mantle-cell lymphoma, has an independently expressed homolog on 1p22-p31, BCMSUN-like.Molecular diagnostic approach to non-Hodgkin's lymphoma.Antigen receptor signaling to NF-kappaB via CARMA1, BCL10, and MALT1.Molecular basis of lysophosphatidic acid-induced NF-κB activationLymphoid malignancies: the dark side of B-cell differentiation.Caspases: conductors of the cell death machinery in lymphoma cells.
P2860
Q24290366-B691986F-B4F1-4C13-A731-5D1A9F1D08E9Q24290440-8B1DD5D6-7765-44C9-B43C-CC2534ED9678Q24291474-343D9857-E631-4A3B-A34F-588C7C8D3248Q24298225-299B6BE4-8026-4371-90A5-5B3966019598Q24300394-C2AD03F4-C15A-4DB8-BBA0-8EF50A3ACC53Q24301605-A5FC7C90-8763-4282-929D-A295D6D99B81Q24306407-9288092E-327A-4042-A726-546A3215644AQ24318385-2582EDDB-368C-4219-AB06-D2402B82B17AQ24336767-C8744D6D-3146-4D94-BA8F-06222541D304Q24534877-B9DC6B77-9514-425E-A72F-383D78A89B7AQ24630605-F9C5A0F2-6489-4CE5-BDCB-F5EF32A39F00Q26851166-C914C190-57D3-48F8-8B40-6924AEB77D83Q28118973-C0B6E7E2-E1DE-4FB5-8BE5-F0B87CACAA0DQ28141188-37FFBDF7-2615-4E9D-9AA5-02261A975FF1Q28198772-95FC4048-32EE-43B9-B5C7-F08D187598F1Q28206030-FB1FDA3C-0C6F-47A2-9328-8088669ACBD6Q28260096-0A61883F-26E1-462D-B2EE-F38C79D9C39CQ28265675-716DD1CB-70B4-493F-AD9B-1856638D0DBEQ28287278-B13AD6F7-1181-4F70-810D-297363F503CDQ28295777-6D260F30-5174-4BF1-ABDA-2724B74BA3BBQ28306819-477A65D5-1974-48DB-AFC8-E6644C6B1820Q28573777-54581F04-2B30-497A-9175-446D0C786AEAQ28589369-BB649523-C22E-4A47-B9DA-90D00DA4D149Q30157639-66AB74E1-0BC2-4543-88C4-848C2C592A96Q33180518-08BC0DD2-61A1-4C70-95AE-AED59F4423A4Q33237976-073BB046-6CDF-4AF1-AAA7-4614D7200340Q33264594-EE5304D9-3564-4746-8867-B1C212957721Q33417259-F090EEA3-61AE-4648-8035-CE3A31C0BABFQ33581388-B59DABF9-7FC7-4486-9D34-87E10A1ACF9DQ33622342-BC3BE8CF-0E5B-4C61-B5CC-18E5F6BA58BCQ33781603-EEBFFFBF-35E9-4A02-9BAB-27B7C9F32F6FQ33849388-41CB1BE3-E27F-421E-9233-785AB3087199Q33885629-C16767D0-92AA-40E0-BFD1-C19DD71AD11DQ33889168-3A5A4CB2-F224-4B23-8B08-BA287EA440D8Q33924832-6EA78175-B8BF-443B-BE4A-28BA63C76555Q33936373-52D41B37-2DBE-4F59-9331-202AD8A3FB8EQ34080225-C95AE533-AF50-4498-933B-14F5A14EDDCCQ34126537-D97275EE-6FAF-49CB-9598-6FD59AA240F3Q34162187-8F1FFFBA-C6F9-46DD-BD8F-B405E726DED1Q34265185-17349F13-F625-49E1-8E50-45861C78F85A
P2860
Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32)
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Inactivating mutations and ove ...... lymphoma with t(1;14)(p22;q32)
@ast
Inactivating mutations and ove ...... lymphoma with t(1;14)(p22;q32)
@en
Inactivating mutations and ove ...... lymphoma with t(1;14)(p22;q32)
@nl
type
label
Inactivating mutations and ove ...... lymphoma with t(1;14)(p22;q32)
@ast
Inactivating mutations and ove ...... lymphoma with t(1;14)(p22;q32)
@en
Inactivating mutations and ove ...... lymphoma with t(1;14)(p22;q32)
@nl
prefLabel
Inactivating mutations and ove ...... lymphoma with t(1;14)(p22;q32)
@ast
Inactivating mutations and ove ...... lymphoma with t(1;14)(p22;q32)
@en
Inactivating mutations and ove ...... lymphoma with t(1;14)(p22;q32)
@nl
P2093
P3181
P356
P1433
P1476
Inactivating mutations and ove ...... lymphoma with t(1;14)(p22;q32)
@en
P2093
A Rosenthal
B Hinzmann
B Schlegelberger
D D Weisenburger
E Callet-Bauchu
G Beckmann
K M Rakestraw
P2888
P3181
P356
10.1038/8767
P407
P577
1999-05-01T00:00:00Z